Table 1.
Detailed patient information.
| Sample ID | Classification | Gender | Age | FC | IHC | RT-qPCR |
|---|---|---|---|---|---|---|
| 111 | CLL | F | 70 | ND | Lambda | Lambda |
| 112 | CLL | F | 82 | ND | Lambda | MNP |
| 113 | CLL | M | 58 | Lambda | Lambda | Lambda |
| 115 | CLL | F | 61 | Lambda | Lambda | Lambda |
| 116 | CLL | F | 57 | Kappa | Kappa | Kappa |
| 117 | CLL | F | 75 | Kappa | Kappa | Kappa |
| 118 | CLL | F | 85 | Kappa | Kappa | Kappa |
| 119 | CLL | F | 48 | ND | Lambda | Lambda |
| 131 | CLL | M | 72 | ND | Lambda | Lambda |
| 132 | CLL | F | 59 | ND | Lambda | Lambda |
| 145 | CLL | F | 76 | Kappa | Kappa | MNP |
| 146 | CLL | M | 46 | Lambda | Lambda | Lambda |
| 147 | CLL | F | 74 | Kappa | Kappa | Kappa |
| 149 | CLL | F | 76 | Kappa | Kappa | MNP |
| 189 | CLL | F | 65 | Kappa | Kappa | MNP |
| 191 | CLL | M | 60 | Lambda | Lambda | Lambda |
| 120 | DLBL | M | 80 | ND | Kappa | MNP |
| 121 | DLBL | M | 81 | ND | Kappa | Kappa |
| 123 | DLBL | M | 64 | Kappa | Kappa | Kappa |
| 124 | DLBL | F | 77 | Kappa | Kappa | Kappa |
| 125 | DLBL | M | 57 | ND | MNP | Lambda |
| 126 | DLBL | M | 70 | Lambda | Lambda | Lambda |
| 127 | DLBL | M | 70 | Kappa | Kappa | Kappa |
| 129 | DLBL | M | 58 | ND | Kappa | MNP |
| 133 | DLBL | M | 72 | MNP | Lambda | MNP |
| 135 | DLBL | F | 75 | MNP | Kappa | Kappa |
| 136 | DLBL | F | 78 | ND | Kappa | MNP |
| 137 | DLBL | M | 70 | Kappa | Kappa | Kappa |
| 138 | DLBL | M | 72 | ND | Kappa | MNP |
| 139 | DLBL | M | 33 | Kappa | Kappa | Kappa |
| 140 | DLBL | F | 78 | Kappa | Kappa | kappa |
| 153 | DLBL | M | 19 | ND | Kappa | Kappa |
| 156 | DLBL | M | 58 | Kappa | Kappa | Kappa |
| 182 | DLBL | F | 75 | MNP | Kappa | MNP |
| 184 | DLBL | M | 55 | Kappa | Kappa | Kappa |
| 186 | DLBL | F | 66 | Kappa | Kappa | Kappa |
| 157 | FL | F | 54 | Kappa | Kappa | MNP |
| 158 | FL | F | 51 | ND | Kappa | MNP |
| 159 | FL | M | 77 | ND | Kappa | MNP |
| 160 | FL | F | 60 | ND | Lambda | MNP |
| 161 | FL | M | 70 | Lambda | Lambda | MNP |
| 162 | FL | M | 69 | Kappa | Kappa | Kappa |
| 163 | FL | M | 52 | Kappa | Kappa | Kappa |
| 164 | FL | M | 53 | ND | Kappa | Kappa |
| 165 | FL | F | 59 | Kappa | Kappa | MNP |
| 166 | FL | M | 61 | MNP | Kappa | MNP |
| 167 | FL | F | 30 | MNP | Lambda | MNP |
| 168 | FL | M | 51 | MNP | Kappa | Kappa |
| 208 | FL | F | 83 | MNP | ND | MNP |
| 209 | FL | F | 55 | Lambda | Lambda | Lambda |
| 210 | FL | F | 46 | MNP | Kappa | MNP |
| 211 | FL | M | 64 | Lambda | ND | MNP |
| 204 | MCL | M | 61 | Lambda | Lambda | Lambda |
| 206 | MCL | F | 78 | Kappa | Kappa | Kappa |
| 207 | MCL | F | 70 | Kappa | Kappa | MNP |
| 101 | LA | F | 62 | ND | MNP | Control |
| 102 | LA | M | 25 | ND | MNP | Control |
| 103 | LA | M | 25 | ND | MNP | Control |
| 104 | LA | M | 16 | ND | MNP | Control |
| 105 | LA | F | 58 | ND | MNP | Control |
| 106 | LA | M | 59 | ND | MNP | Control |
| 107 | LA | M | 41 | ND | MNP | Control |
| 108 | LA | M | 7 | ND | MNP | Control |
| 109 | LA | F | 33 | ND | MNP | Control |
| 110 | LA | F | 28 | ND | MNP | Control |
| 192 | LA | F | 1 | MNP | MNP | Control |
| 193 | LA | F | 40 | MNP | MNP | Control |
| 194 | LA | M | 28 | MNP | MNP | Control |
| 195 | LA | M | 20 | MNP | MNP | Control |
| 196 | LA | M | 13 | MNP | MNP | Control |
| 197 | LA | M | 30 | MNP | MNP | Control |
| 198 | LA | F | 10 | MNP | MNP | Control |
| 199 | LA | F | 58 | MNP | MNP | Control |
| 200 | LA | M | 49 | MNP | MNP | Control |
| 201 | LA | F | 57 | MNP | MNP | Control |
CLL: chronic lymphocytic leukemia; DLBL: diffuse large B cell lymphoma; FL: follicular lymphoma; LA: lymphadenitis; F: female; M: male; MNP: monoclonality not proven; FC: flow cytometry; IHC: immunohistochemistry.